Collegium Pharmaceutical, Inc. Financials

Market Capitalization $975.5 Million as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	24.88
Forward PE	4.56
Price to Sales TTM	$1.47
Price to Book MRQ	$4.16
Enterprise to Revenue	2.59
Enterprise to EBITDA	4.71

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	6.61%
Operating Margin	13.71%
Return on Assets TTM	7.95%
Return on Equity TTM	19.23%

Income Statement

Revenue TTM	$664,283,008
Revenue per Share TTM	$20.67
Quarterly Revenue Growth	22.70%
Gross Profit TTM	$578,217,984
EBITDA	$340,412,000
Net Income to Common TTM	$43,894,000
Diluted EPS TTM	$1.22
Quarterly Earnings Growth YoY	-91.30%

Balance Sheet

Total Cash MRQ	$197,774,000
Total Cash per Share MRQ	$6.15
Total Debt MRQ	$
Total Debt to Equity MRQ	411.94
Current Ratio MRQ	1.08
Book Value per Share MRQ	$7.30

Cash Flow

Operating Cash Flow TTM	$198,440,992
Levered Free Cash Flow TTM	$341,319,136

COLL Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	31,440,155
Float Shares	27,235,365
Avg 10 Volume	291,320
Avg 30 Volume	None
Shares Short	4,816,415
Short Ratio	17.76
Short % of Shares	17.88%
% Held by Insiders	1.69%
% Held by Institutions	117.12%

Stock Price Summary

Beta	0.65
Fifty Two Week Low	$23.23
Fifty Two Week High	$42.29
Fifty Two Week Change	-5.11%
Day 50 MA	$29.02
Day 200 MA	$31.15

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date